Multiple Assemblies exist for SMTL entry 6fw3
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-007; X-RAY DIFFRACTION 1.78 Å

	SMTL ID 6fw3.1 Ligands ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; DI(HYDROXYETHYL)ETHER; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; 1-(2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-1,2,4a,5,8,8a-hexahydrophthalazin-2-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione Polypeptides cAMP-specific 3',5'-cyclic phosphodiesterase 4D Oligo-state monomer
	SMTL ID 6fw3.2 Ligands ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; 1-(2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-1,2,4a,5,8,8a-hexahydrophthalazin-2-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione Polypeptides cAMP-specific 3',5'-cyclic phosphodiesterase 4D Oligo-state monomer
	SMTL ID 6fw3.3 Ligands 1,2-ETHANEDIOL; ZINC ION; MAGNESIUM ION; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; 1-(2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-1,2,4a,5,8,8a-hexahydrophthalazin-2-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione; TETRAETHYLENE GLYCOL Polypeptides cAMP-specific 3',5'-cyclic phosphodiesterase 4D Oligo-state monomer
	SMTL ID 6fw3.4 Ligands 1,2-ETHANEDIOL; ZINC ION; MAGNESIUM ION; DI(HYDROXYETHYL)ETHER; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; 1-(2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-1,2,4a,5,8,8a-hexahydrophthalazin-2-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione Polypeptides cAMP-specific 3',5'-cyclic phosphodiesterase 4D Oligo-state monomer